| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 13.54M | — |
| Operating expense | — | — |
| Net income | -40.55M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, TNXP returned -67.0% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -19.7% |
| 1 year | -67.0% |
| 5 years | -100.0% |
| 10 years | -100.0% |
| All-time high | $12,800,000,000.00 (Jun 2012) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in TNXP would be worth today ›No. Tonix Pharmaceuticals Holding Corp. has not paid a dividend in the past 12 months.
Tonix Pharmaceuticals Holding Corp. stock trades on NASDAQ under the ticker symbol TNXP.
Tonix Pharmaceuticals Holding Corp. is part of the Healthcare sector.
Tonix Pharmaceuticals Holding Corp. has a market cap of 215.25M USD, based on the latest quote.
Tonix Pharmaceuticals Holding Corp. is scheduled to report earnings on Nov 9, 2026.
